Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Jazz Pharmaceuticals (JAZZ) Q4 2024 Earnings
JAZZ
6
Nov
Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
2.68
3.99
5.3
6.61
Details
Expected EPS
5.498318
Actual EPS
6.61
Surprise EPS
1.11
Surprise Percent
+20.22%
Description
Jazz Pharmaceuticals (JAZZ) has reported earnings of 6.61 per share for Q4 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login